{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:02:04Z","timestamp":1794376924162,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201427"],"award-info":[{"award-number":["82201427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304211"],"award-info":[{"award-number":["82304211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04781-9","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:17:19Z","timestamp":1769681839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Explainable machine learning integrating biochemical and metabolomic biomarkers with conventional clinical factors improves chronic kidney disease prediction and risk stratification"],"prefix":"10.1186","volume":"27","author":[{"given":"Jing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-3563","authenticated-orcid":false,"given":"Xiru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"4781_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in china: A cross-sectional survey. Lancet Lond Engl. 2012;379:815\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(12)60033-6.","journal-title":"Lancet Lond Engl"},{"key":"4781_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12:7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003.","journal-title":"Kidney Int Suppl"},{"key":"4781_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048\u201350. https:\/\/doi.org\/10.1016\/j.kint.2019.07.012.","journal-title":"Kidney Int"},{"key":"4781_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322:1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"JAMA"},{"key":"4781_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ki.2014.190","volume":"86","author":"J Radhakrishnan","year":"2014","unstructured":"Radhakrishnan J, Remuzzi G, Saran R, Williams DE, Rios-Burrows N, Powe N, et al. Taming the chronic kidney disease epidemic: A global view of surveillance efforts. Kidney Int. 2014;86:246\u201350. https:\/\/doi.org\/10.1038\/ki.2014.190.","journal-title":"Kidney Int"},{"key":"4781_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamaneurol.2022.2299","volume":"79","author":"KN Vanent","year":"2022","unstructured":"Vanent KN, Leasure AC, Acosta JN, Kuohn LR, Woo D, Murthy SB, et al. Association of chronic kidney disease with risk of intracerebral hemorrhage. JAMA Neurol. 2022;79:911\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2299.","journal-title":"JAMA Neurol"},{"key":"4781_CR7","doi-asserted-by":"publisher","first-page":"c4249","DOI":"10.1136\/bmj.c4249","volume":"341","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Chang K-H, Liao H-W, Chang S-C, Ovbiagele B. Low glomerular filtration rate and risk of stroke: Meta-analysis. BMJ. 2010;341:c4249. https:\/\/doi.org\/10.1136\/bmj.c4249.","journal-title":"BMJ"},{"key":"4781_CR8","doi-asserted-by":"publisher","first-page":"e026685","DOI":"10.1161\/JAHA.122.026685","volume":"11","author":"Y Choi","year":"2022","unstructured":"Choi Y, Jacobs DR, Shroff GR, Kramer H, Chang AR, Duprez DA. Progression of chronic kidney disease risk categories and risk of cardiovascular disease and total mortality: coronary artery risk development in young adults cohort. J Am Heart Assoc. 2022;11:e026685. https:\/\/doi.org\/10.1161\/JAHA.122.026685.","journal-title":"J Am Heart Assoc"},{"key":"4781_CR9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"key":"4781_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/eurheartj\/ehi880","volume":"27","author":"C Meisinger","year":"2006","unstructured":"Meisinger C, D\u00f6ring A, L\u00f6wel H, KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006;27:1245\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehi880.","journal-title":"Eur Heart J"},{"key":"4781_CR11","doi-asserted-by":"publisher","unstructured":"Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99:34\u201347. https:\/\/doi.org\/10.1016\/j.kint.2020.10.012.","DOI":"10.1016\/j.kint.2020.10.012"},{"key":"4781_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2015121308","volume":"28","author":"ED O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan ED, Hughes J, Ferenbach DA. Renal aging: causes and consequences. J Am Soc Nephrol JASN. 2017;28:407\u201320. https:\/\/doi.org\/10.1681\/ASN.2015121308.","journal-title":"J Am Soc Nephrol JASN"},{"key":"4781_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151\u201364. https:\/\/doi.org\/10.1038\/nrneph.2017.181.","journal-title":"Nat Rev Nephrol"},{"key":"4781_CR14","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2019.17379","volume":"322","author":"RG Nelson","year":"2019","unstructured":"Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322:2104\u201314. https:\/\/doi.org\/10.1001\/jama.2019.17379.","journal-title":"JAMA"},{"key":"4781_CR15","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","volume":"28","author":"T Buergel","year":"2022","unstructured":"Buergel T, Steinfeldt J, Ruyoga G, Pietzner M, Bizzarri D, Vojinovic D, et al. Metabolomic profiles predict individual multidisease outcomes. Nat Med. 2022;28:2309\u201320. https:\/\/doi.org\/10.1038\/s41591-022-01980-3.","journal-title":"Nat Med"},{"key":"4781_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","volume":"14","author":"H Julkunen","year":"2023","unstructured":"Julkunen H, Cicho\u0144ska A, Tiainen M, Koskela H, Nybo K, M\u00e4kel\u00e4 V, et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK biobank. Nat Commun. 2023;14:604. https:\/\/doi.org\/10.1038\/s41467-023-36231-7.","journal-title":"Nat Commun"},{"key":"4781_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s41467-019-09329-0","volume":"10","author":"D-Q Chen","year":"2019","unstructured":"Chen D-Q, Cao G, Chen H, Argyopoulos CP, Yu H, Su W, et al. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. Nat Commun. 2019;10:1476. https:\/\/doi.org\/10.1038\/s41467-019-09329-0.","journal-title":"Nat Commun"},{"key":"4781_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/pr3007792","volume":"12","author":"Y-Y Zhao","year":"2013","unstructured":"Zhao Y-Y, Cheng X-L, Wei F, Bai X, Tan X-J, Lin R-C, et al. Intrarenal metabolomic investigation of chronic kidney disease and its TGF-\u03b21 mechanism in induced-adenine rats using UPLC Q-TOF\/HSMS\/MS(E). J Proteome Res. 2013;12:692\u2013703. https:\/\/doi.org\/10.1021\/pr3007792.","journal-title":"J Proteome Res"},{"key":"4781_CR19","doi-asserted-by":"publisher","first-page":"e81878","DOI":"10.7554\/eLife.81878","volume":"12","author":"C Sabanayagam","year":"2023","unstructured":"Sabanayagam C, He F, Nusinovici S, Li J, Lim C, Tan G, et al. Prediction of diabetic kidney disease risk using machine learning models: A population-based cohort study of Asian adults. eLife. 2023;12:e81878. https:\/\/doi.org\/10.7554\/eLife.81878.","journal-title":"eLife"},{"key":"4781_CR20","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.2337\/db20-0586","volume":"69","author":"J Huang","year":"2020","unstructured":"Huang J, Huth C, Covic M, Troll M, Adam J, Zukunft S, et al. Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes. Diabetes. 2020;69:2756\u201365. https:\/\/doi.org\/10.2337\/db20-0586.","journal-title":"Diabetes"},{"key":"4781_CR21","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"4781_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jacc.2021.05.004","volume":"78","author":"MC Honigberg","year":"2021","unstructured":"Honigberg MC, Zekavat SM, Pirruccello JP, Natarajan P, Vaduganathan M. Cardiovascular and kidney outcomes across the glycemic spectrum: insights from the UK biobank. J Am Coll Cardiol. 2021;78:453\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2021.05.004.","journal-title":"J Am Coll Cardiol"},{"key":"4781_CR23","doi-asserted-by":"publisher","first-page":"102323","DOI":"10.1016\/j.eclinm.2023.102323","volume":"66","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu Y-M, Lei F, Huang X, Liu W, Sun T, et al. Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK biobank: A prospective cohort study. EClinicalMedicine. 2023;66:102323. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102323.","journal-title":"EClinicalMedicine"},{"key":"4781_CR24","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.aap.2020.105744","volume":"146","author":"L Li","year":"2020","unstructured":"Li L, Prato CG, Wang Y. Ranking contributors to traffic crashes on mountainous freeways from an incomplete dataset: A sequential approach of multivariate imputation by chained equations and random forest classifier. Accid Anal Prev. 2020;146:105744. https:\/\/doi.org\/10.1016\/j.aap.2020.105744.","journal-title":"Accid Anal Prev"},{"key":"4781_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nmeth.3414","volume":"12","author":"A Kulesa","year":"2015","unstructured":"Kulesa A, Krzywinski M, Blainey P, Altman N. Sampling distributions and the bootstrap. Nat Methods. 2015;12:477\u20138. https:\/\/doi.org\/10.1038\/nmeth.3414.","journal-title":"Nat Methods"},{"key":"4781_CR26","doi-asserted-by":"publisher","first-page":"bbab354","DOI":"10.1093\/bib\/bbab354","volume":"23","author":"A Bommert","year":"2022","unstructured":"Bommert A, Welchowski T, Schmid M, Rahnenf\u00fchrer J. Benchmark of filter methods for feature selection in high-dimensional gene expression survival data. Brief Bioinform. 2022;23:bbab354. https:\/\/doi.org\/10.1093\/bib\/bbab354.","journal-title":"Brief Bioinform"},{"key":"4781_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2215\/CJN.12791019","volume":"15","author":"AS Levey","year":"2020","unstructured":"Levey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR Estimation. Clin J Am Soc Nephrol CJASN. 2020;15:1203\u201312. https:\/\/doi.org\/10.2215\/CJN.12791019.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"4781_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"4781_CR29","unstructured":"Prokhorenkova L, Gusev G, Vorobev A, Dorogush AV, Gulin A. CatBoost: unbiased boosting with categorical features. In: Proceedings of the 32nd International Conference on Neural Information Processing Systems. Red Hook, NY, USA: Curran Associates Inc.; 2018. pp. 6639\u201349."},{"key":"4781_CR30","doi-asserted-by":"publisher","unstructured":"Dorogush AV, Ershov V, Gulin A. CatBoost: gradient boosting with categorical features support. 2018. http:\/\/arxiv.org\/abs\/1810.11363. Accessed 22 Feb 2025. 2018. https:\/\/doi.org\/10.48550\/arXiv.1810.11363","DOI":"10.48550\/arXiv.1810.11363"},{"key":"4781_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global Understanding with explainable AI for trees. Nat Mach Intell. 2020;2:56\u201367. https:\/\/doi.org\/10.1038\/s42256-019-0138-9.","journal-title":"Nat Mach Intell"},{"key":"4781_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/dc20-1536","volume":"44","author":"W Gou","year":"2021","unstructured":"Gou W, Ling C-W, He Y, Jiang Z, Fu Y, Xu F, et al. Interpretable machine learning framework reveals robust gut Microbiome features associated with type 2 diabetes. Diabetes Care. 2021;44:358\u201366. https:\/\/doi.org\/10.2337\/dc20-1536.","journal-title":"Diabetes Care"},{"key":"4781_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease, Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007.","journal-title":"Ann Intern Med"},{"key":"4781_CR34","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2011.468","volume":"305","author":"CA Peralta","year":"2011","unstructured":"Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, Cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545\u201352. https:\/\/doi.org\/10.1001\/jama.2011.468.","journal-title":"JAMA"},{"key":"4781_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-147-1-200707030-00004","volume":"147","author":"V Menon","year":"2007","unstructured":"Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med. 2007;147:19\u201327. https:\/\/doi.org\/10.7326\/0003-4819-147-1-200707030-00004.","journal-title":"Ann Intern Med"},{"key":"4781_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Cholesterol and recurrent events (CARE) trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237\u201345. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00398.x.","journal-title":"Kidney Int"},{"key":"4781_CR37","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: A report from an ADA consensus conference. Diabetes Care. 2014;37:2864\u201383. https:\/\/doi.org\/10.2337\/dc14-1296.","journal-title":"Diabetes Care"},{"key":"4781_CR38","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1681\/ASN.2007101075","volume":"19","author":"DE Weiner","year":"2008","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. J Am Soc Nephrol JASN. 2008;19:1204\u201311. https:\/\/doi.org\/10.1681\/ASN.2007101075.","journal-title":"J Am Soc Nephrol JASN"},{"key":"4781_CR39","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK, Gout. Lancet. 2016;388:2039\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(16)00346-9.","journal-title":"Lancet"},{"key":"4781_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrneph.2011.62","volume":"7","author":"V Krane","year":"2011","unstructured":"Krane V, Wanner C. Statins, inflammation and kidney disease. Nat Rev Nephrol. 2011;7:385\u201397. https:\/\/doi.org\/10.1038\/nrneph.2011.62.","journal-title":"Nat Rev Nephrol"},{"key":"4781_CR41","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1093\/eurheartj\/ehac444","volume":"43","author":"PM Ridker","year":"2022","unstructured":"Ridker PM, Tuttle KR, Perkovic V, Libby P, MacFadyen JG. Inflammation drives residual risk in chronic kidney disease: A CANTOS substudy. Eur Heart J. 2022;43:4832\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehac444.","journal-title":"Eur Heart J"},{"key":"4781_CR42","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/cells12121581","volume":"12","author":"SP Kadatane","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12:1581. https:\/\/doi.org\/10.3390\/cells12121581.","journal-title":"Cells"},{"key":"4781_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.ajkd.2014.05.024","volume":"65","author":"LA Bach","year":"2015","unstructured":"Bach LA, Hale LJ. Insulin-like growth factors and kidney disease. Am J Kidney Dis Off J Natl Kidney Found. 2015;65:327\u201336. https:\/\/doi.org\/10.1053\/j.ajkd.2014.05.024.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"4781_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2215\/CJN.02470213","volume":"9","author":"T Jia","year":"2014","unstructured":"Jia T, Gama Axelsson T, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Lindholm B, Stenvinkel P, et al. IGF-1 and survival in ESRD. Clin J Am Soc Nephrol CJASN. 2014;9:120\u20137. https:\/\/doi.org\/10.2215\/CJN.02470213.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"4781_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305:1553\u20139. https:\/\/doi.org\/10.1001\/jama.2011.451.","journal-title":"JAMA"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04781-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:24:46Z","timestamp":1771597486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04781-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4781"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04781-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research complied with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to their involvement, and ethical approval was granted by the North West Multi-Center Research Ethics Committee (reference: 11\/NW\/0382). Any additional ethical approval was adjudged unnecessary for the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}